| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
100,320,000 |
| Market
Cap: |
243.78(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.43 - $2.43 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Zymergen integrates computational and manufacturing technologies to design, develop, and commercialize bio-based breakthrough products in a range of industries. Co. has developed a platform based on its collection of accessible biomolecules, its software and data science technology and its data driven microbe optimization processes. Utilizing its platform, Co. is building several businesses, including: advanced materials, which seeks to employ bio-advantaged molecules or microbes to develop and deliver products; and drug discovery, which utilizes its differentiated access to natural products as a source of chemical matter provided by its unified metagenomics database.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
52,724 |
| Total Sell Value |
$0 |
$0 |
$0 |
$123,277 |
| Total People Sold |
0 |
0 |
0 |
3 |
| Total Sell Transactions |
0 |
0 |
0 |
12 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Softbank Vision Fund (aiv M1) L.p. |
10% Owner |
– – • |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(26,614,219) |
0 |
|
- |
|
| Singh Enakshi |
Chief Financial Officer |
• – – |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(462,241) |
0 |
|
- |
|
| Chu Steven |
Director |
– • – |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(50,000) |
0 |
|
- |
|
| Murdoch Travis |
Director |
– • – |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(79,697) |
0 |
|
- |
|
| Ocko Matthew |
Director |
– • – |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,366,635) |
0 |
|
- |
|
| Gorjanc Christine Marie |
Director |
– • – |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(50,000) |
0 |
|
- |
|
| Peterson Sandra E |
Director |
– • – |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(119,119) |
0 |
|
- |
|
| Serber Zachariah |
Director |
– • – |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(80,000) |
0 |
|
- |
|
| Serber Zachariah |
Director |
– • – |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,551,685) |
0 |
|
- |
|
| Flatley Jay T |
Chairman and Acting CEO |
• • – |
2022-10-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(144,789) |
0 |
|
- |
|
| Singh Enakshi |
Chief Financial Officer |
• – – |
2022-10-03 |
4 |
S |
$2.80 |
$10,598 |
D/D |
(3,786) |
462,241 |
|
12% |
|
| Kim Mina |
Chief Legal Officer |
• – – |
2022-09-02 |
4 |
S |
$2.21 |
$7,536 |
D/D |
(3,410) |
298,427 |
|
-10% |
|
| Singh Enakshi |
Chief Financial Officer |
• – – |
2022-09-02 |
4 |
S |
$2.21 |
$8,681 |
D/D |
(3,928) |
466,027 |
|
-10% |
|
| Serber Zachariah |
Chief Science Officer |
• • – |
2022-09-02 |
4 |
S |
$2.21 |
$7,222 |
D/D |
(3,268) |
2,551,685 |
|
-10% |
|
| Singh Enakshi |
Chief Financial Officer |
• – – |
2022-08-30 |
4 |
S |
$2.27 |
$34,946 |
D/D |
(15,365) |
469,955 |
|
-7% |
|
| Singh Enakshi |
Chief Financial Officer |
• – – |
2022-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,320 |
485,320 |
|
- |
|
| Serber Zachariah |
Chief Science Officer |
• • – |
2022-08-11 |
4 |
AS |
$3.91 |
$21,251 |
D/D |
(5,435) |
2,554,953 |
|
-19% |
|
| Kim Mina |
Chief Legal Officer |
• – – |
2022-08-02 |
4 |
S |
$2.61 |
$8,083 |
D/D |
(3,094) |
301,837 |
|
6% |
|
| Serber Zachariah |
Chief Science Officer |
• • – |
2022-08-02 |
4 |
S |
$2.61 |
$7,749 |
D/D |
(2,966) |
2,560,388 |
|
6% |
|
| Serber Zachariah |
Chief Science Officer |
• • – |
2022-07-05 |
4 |
S |
$1.32 |
$3,698 |
D/D |
(2,797) |
2,563,354 |
|
-79% |
|
| Kim Mina |
Chief Legal Officer |
• – – |
2022-07-05 |
4 |
S |
$1.32 |
$3,866 |
D/D |
(2,924) |
304,931 |
|
-79% |
|
| Murdoch Travis |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
79,697 |
|
- |
|
| Gorjanc Christine Marie |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Peterson Sandra E |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
119,119 |
|
- |
|
| Kim Mina |
Chief Legal Officer |
• – – |
2022-06-02 |
4 |
S |
$1.68 |
$4,930 |
D/D |
(2,939) |
307,855 |
|
-52% |
|
65 Records found
|
|
Page 1 of 3 |
|
|
